Vanguard Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87B Buy
1,556,634
+166,734
+12% +$170M 1.26% 12
2026
Q1
$1.28B Buy
+1,389,900
New +$1.41B 1.09% 13

Other funds holding LLY

Vanguard Asset Management's LLY Position: Q2 2026 in Review

Vanguard Asset Management increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $170M and bringing the position to 1,556,634 shares worth $1.87B. The position accounts for 1.26% of the portfolio, ranked #12.

Vanguard Asset Management first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Vanguard Asset Management held 1,556,634 shares of Eli Lilly worth $1.87B as of Q2 2026.
  • Vanguard Asset Management bought 166,734 Eli Lilly shares in Q2 2026, an estimated $170M.
  • Eli Lilly made up 1.26% of Vanguard Asset Management's portfolio in Q2 2026, its #12 holding.
  • Vanguard Asset Management first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.